Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
First- and second-trimester evaluation of risk for Down syndrome
Robert H. Ball
, Aaron B. Caughey
, Fergal D. Malone
, David A. Nyberg
, Christine H. Comstock
, George R. Saade
, Richard L. Berkowitz
, Susan J. Gross
, Lorraine Dugoff
, Sabrina D. Craigo
, Ilan E. Timor-Tritsch
, Stephen R. Carr
, Honor M. Wolfe
, Danielle Emig
, Mary E. D'Alton
Research output
:
Contribution to journal
›
Article
›
peer-review
89
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'First- and second-trimester evaluation of risk for Down syndrome'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
First Trimester
100%
Second Trimester
100%
Risk Evaluation
100%
Down Syndrome
100%
Quad
57%
Pregnancy-associated Plasma protein-A (PAPP-A)
42%
False Positive Rate
42%
Fetus
28%
Nuchal Translucency
28%
Estriol
28%
Inhibin
28%
Down Syndrome Screening
28%
Amniocentesis
28%
Miscarriage
28%
Quality-adjusted Life Years
28%
Maternal Serum alpha-fetoprotein (MSAFP)
28%
Health Care Costs
14%
High Cost
14%
Screening Test
14%
Screen Positive
14%
Live Birth
14%
Sensitivity Analysis
14%
Complication Management
14%
Incremental Cost-effectiveness Ratio
14%
Detection Rate
14%
Triple Screen
14%
Sequential Test
14%
Syndrome Diagnosis
14%
Complications of Care
14%
Quad Screen
14%
Cost Management
14%
Future Policy
14%
Therapeutic Abortion
14%
Societal Costs
14%
Sequential Strategy
14%
Medicine and Dentistry
Health Care Cost
100%
Second Trimester Pregnancy
100%
First Trimester Pregnancy
100%
Down Syndrome
100%
False Positive Result
33%
Pregnancy-Associated Plasma Protein A
33%
Nuchal Translucency Measurement
22%
Spontaneous Abortion
22%
Maternal Serum
22%
Estriol
22%
Alpha-Fetoprotein
22%
Amniocentesis
22%
Quality Adjusted Life Year
22%
Screening Test
11%
Inhibin A
11%
Sequential Analysis
11%
Therapeutic Abortion
11%
Pharmacology, Toxicology and Pharmaceutical Science
Down Syndrome
100%
Pregnancy Associated Plasma Protein A
33%
Estriol
22%
Spontaneous Abortion
22%
Alpha Fetoprotein
22%
Inhibin A
11%